繁体中文
设为首页
加入收藏
当前位置:药品说明书与价格首页 >> 呼吸系统病 >> 慢性阻塞性肺病 >> Anoro Ellipta(Umeclidinium Bromide/Vilanterol Trifenatate)

Anoro Ellipta(Umeclidinium Bromide/Vilanterol Trifenatate)

2014-09-14 04:22:15  作者:新特药房  来源:互联网  浏览次数:270  文字大小:【】【】【
简介:英文药名:Anoro Ellipta 7puffs(umeclidinium/vilanterol) 中文药名:芜地溴铵/维兰特罗吸入剂 日文药名:アノーロエリプタ7吸入用 生产厂家:日本葛兰素史克公司药品介绍商品名:Anoro Ellipta 通用名: ...

英文药名:Anoro Ellipta(Umeclidinium Bromide/Vilanterol Trifenatate)

中文药名:芜地溴铵/维兰特罗吸入剂

日文药名:アノーロエリプタ 吸入用

生产厂家:葛兰素史克公司
治疗类别名称
慢性阻塞性肺病的治疗配方
商品名:
ANORO ELLIPTA 7doses
ANORO ELLIPTA 30doses
通用名:Umeclidinium Bromide/Vilanterol Trifenatate
中文名:
芜地溴铵/维兰特罗
活性成分:
芜地溴铵(umeclidinium bromide/62.5mcg)和维兰特罗(vilanterol/25mcg)
作用机理:
芜地溴铵是一种长效胆碱受体拮抗剂(LAMA),维兰特罗是一种长效肾上腺素β2受体激动剂(LABA),能够舒张支气管平滑肌。
适应病症:
长期维持治疗慢性阻塞性肺病。
用法与用量
本品为复方口腔吸入粉,每天用药一次,每次芜地溴铵/62.5mcg 维兰特罗/25mcg
黑框警告:
哮喘相关致死风险(LABA引起)。
不良反应:支气管痉挛、心血管风险、眼内压升高、尿潴留、咽喉肿痛、鼻窦感染、下呼吸道感染、便秘、腹泻、四肢疼痛、肌肉痉挛、颈部疼痛、胸部疼痛。
包装规格
74.2μg/62.5μg
7吸入×1
30吸入×1


制造商(进口)
日本葛兰素史克公司
注:以上中文资料仅供参考,使用以原处方为准:http://www.info.pmda.go.jp/go/pack/2259806G1021_1_03/
Anoro Ellipta(Umeclidinium Bromide/Vilanterol Trifenatate)
Anoro Ellipta 7 doses(アノーロエリプタ7吸入用)
 
Brand name : Anoro Ellipta 7 doses
 Active ingredient: Umeclidinium Bromide
 Vilanterol Trifenatate
 Dosage form: Inhalation
 Print on wrapping:
Anoro Ellipta 30 doses(アノーロエリプタ30吸入用) 
Brand name : Anoro Ellipta 30 doses
 Active ingredient: Umeclidinium Bromide
 Vilanterol Trifenatate
 Dosage form: Inhalation
 Print on wrapping: 
Effects of this medicine
This medicine has a long bronchodilator effect by a beta 2 adrenergic receptor stimulating action and by a muscarinic receptor antagonist action. This will help relieve symptoms such as breathing difficulty caused by airway obstruction. It is usually used to treat Chronic Obstructive Pulmonary Disease (chronic bronchitis, pulmonary emphysema). It should not be used to relieve a sudden attack that has already begun.
Before using this medicine, be sure to tell your doctor and pharmacist
•If you have previously experienced any allergic reactions (itch, rash, etc.) to any medicines.
If you have angle-closure glaucoma, difficulty in urination due to prostate hypertrophy.
•If you are pregnant or breastfeeding.
•If you are taking any other medicinal products. (Some medicines may interact to enhance or diminish medicinal effects. Beware of over-the-counter medicines and dietary supplements as well as other prescription medicines.)
Dosing schedule (How to take this medicine)
•Your dosing schedule prescribed by your doctor is <<to be written by a healthcare professional>>
•In general, for adults, inhale one puff at a time, once a day. Strictly follow the instructions.
•Try to inhale this medicine at the same time each day.
•Read the instruction leaflet for users thoroughly before using this medicine.
•To wash away medicine in the mouth and/or throat, gargle after inhaling this medicine. (if you have difficulty gargling, rinse out your mouth.)
•If you miss a dose, inhale a dose as soon as possible. However, do not inhale this medicine more than once a day. You should never take two doses at one time.
•If you accidentally take more than your prescribed dose, consult with your doctor or pharmacist.
•Do not stop taking this medicine unless your doctor instructs you to do so.
Precautions while taking this medicine
• Possible adverse reactions to this medicine
The most commonly reported adverse reactions include headache, dry mouth, cough, taste abnormality and high blood pressure. If any of these symptoms occur, consult with your doctor or pharmacist.
The symptoms described below are rarely seen as initial symptoms of the adverse reactions indicated in brackets. If any of these symptoms occur, stop taking this medicine and see your doctor immediately.
•palpitation, dizziness, faint [Atrial fibrillation]
The above symptoms do not describe all the adverse reactions to this medicine. Consult with your doctor or pharmacist if you notice any symptoms of concern other than those listed above.
Storage conditions and other information
•Keep out of the reach of children. Store away from direct sunlight, heat and moisture.
•Discard the remainder. Do not store them.
GlaxoSmithKline K.K.External
Published: 10/2015
The information on this sheet is based on approvals granted by the Japanese regulatory authority. Approval details may vary by country. Medicines have adverse reactions (risks) as well as efficacies (benefits). It is important to minimize adverse reactions and maximize efficacy. To obtain a better therapeutic response, patients should understand their medication and cooperate with the treatment.

责任编辑:admin


相关文章
ENCRUSE 62.5μg ELLIPTA(Umeclidinium Bromide)
Arnuity Ellipta(Fluticasone Furoate Inhalation Powder)
慢性阻塞性肺病新药Incruse Ellipta(Umeclidinium)获欧盟批准上市
Incruse Ellipta(Umeclidinium Inhalation Powder)新型干粉吸入器
Breo Ellipta(fluticasone furoate and vilanterol inhalation powder)
Anoro Ellipta(芜地溴铵/维兰特罗粉吸入剂)
Relvar Ellipta(fluticasone furoate/vilanterol,FF/VI)新复方药物
RELVAR ELLIPTA(复方三氟甲磺酸维兰特罗氟替卡松糠吸入剂)
Anoro Ellipta(umeclidinium/vilanterol的混合吸入粉剂)
Breo Ellipta(肾上腺皮质激素氟替卡松100μg+长效β受体激动剂维兰特罗25μg)
 

最新文章

更多

· ENCRUSE 62.5μg ELLIPT...
· Ofev(Nintedanib Capsules)
· STIOLTO RESPIMAT(tiotr...
· Seebri Breezhaler(格隆...
· Duaklir Genuair(复方阿...
· Arnuity Ellipta(Flutic...
· Incruse 55micrograms i...
· onbrez inhalation caps...
· Incruse Ellipta(Umecli...
· TOBI PODHALER(妥布霉素...

推荐文章

更多

· ENCRUSE 62.5μg ELLIPT...
· Ofev(Nintedanib Capsules)
· STIOLTO RESPIMAT(tiotr...
· Seebri Breezhaler(格隆...
· Duaklir Genuair(复方阿...
· Arnuity Ellipta(Flutic...
· Incruse 55micrograms i...
· onbrez inhalation caps...
· Incruse Ellipta(Umecli...
· TOBI PODHALER(妥布霉素...

热点文章

更多

· ENCRUSE 62.5μg ELLIPT...